Sumit Sharma
Nutralytics Edtech LLP, Frontro Pharmaceuticals Pvt Ltd, Jamia Hamdard
Research areas: Medicine · Infectious Diseases · Tuberculosis Research and Epidemiology · Pharmacogenetics and Drug Metabolism · Cardiac Fibrosis and Remodeling
0000-0003-4521-3096
About
I am a pharmacologist and toxicologist with over a decade of experience in preclinical research, academic writing, and translational science. My work focuses on pharmacological evaluation of bioactive compounds, oxidative stress mechanisms, and nanoformulation-based drug delivery approaches. I have authored multiple peer-reviewed publications and actively contribute to systematic reviews, meta-analyses, and research methodology development.
In addition to experimental research, I specialize in scientific and medical writing, including manuscript preparation, grant writing, and regulatory-style documentation. I am currently expanding my expertise in regulatory writing, with a focus on eCTD dossier preparation and alignment with ICH guidelines.
My broader research interests include cardiometabolic disorders, neuroprotection, phytopharmacology, and the integration of innovative therapeutic strategies with evidence-based approaches.
Employment
-
Nutralytics Edtech LLP Director2024 - Present
-
Jamia Hamdard Research Associate2021 - 2023
-
Frontro Pharmaceuticals Pvt Ltd Director2017 - Present
Education
-
Jamia Hamdard PhD2013 - 2019
Projects & Funding
Projects & funding information is unavailable.
Publications (20)
- Engineering Natural Killer Cells for Cancer Immunotherapy: Advances, Challenges, and Future Perspectives Save
- Mathematical Modelling and Predictive Analytics for Antimicrobial Resistance Dynamics: A Scoping Review Save
- Artificial Intelligence Across the Surgical Oncology Continuum: Decision Support, Operative Intelligence, and a Translation-First Roadmap Save
- Application of Machine Learning in Autoimmune Diseases: A Review of Current Trends and Future Prospects Save
- Role of BMP-7 in Cardiovascular Diseases: From Molecular Mechanisms to Therapeutic Horizons Save
- D-Pinitol improves cognitive dysfunction and neuronal damage induced by isoproterenol via modulation of NF-κB/BDNF/ GFAP signaling in Swiss albino mice Save
- Protective Effects of Raspberry Ketone against Isoproterenol-Induced Cardiac Hypertrophy in Wistar Rats Save
- Evaluation of the protective effect of Raspberry ketone in gentamicin-induced nephrotoxicity in Wistar rats Save
- Icariin ameliorates oxidative stress-induced inflammation, apoptosis, and heart failure in isoproterenol-challenged Wistar rats Save
- Pathogenic mechanisms and therapeutic promise of phytochemicals and nanocarriers based drug delivery against radiotherapy-induced neurotoxic manifestations Save
- Icariin attenuates isoproterenol-induced cardiac toxicity in Wistar rats via modulating cGMP level and NF-κB signaling cascade. Save
- Nerolidol attenuates cyclophosphamide-induced cardiac inflammation, apoptosis and fibrosis in Swiss Albino mice. Save
- Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: Plausible role of Nrf2 and NF- κB Save
- Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision. Save
- Suppression of isoproterenol-induced cardiotoxicity in rats by raspberry ketone via activation of peroxisome proliferator activated receptor-α. Save
- Intranasally administered pitavastatin ameliorates pentylenetetrazol-induced neuroinflammation, oxidative stress and cognitive dysfunction. Save
- Prophylactic treatment with icariin prevents isoproterenol-induced myocardial oxidative stress via nuclear Factor-Like 2 activation Save
- Raspberry ketone protects against isoproterenol-induced myocardial infarction in rats. Save
- CLINICAL UPDATES ON DRUG - INDUCED CARDIOTOXICITY Save
- Prophylactic treatment with icariin prevents isoproterenol-induced myocardial oxidative stress via nuclear Factor-Like 2 activation Save